| Current Price | $110.39 | Mkt Cap | $43.5B |
|---|---|---|---|
| Open | $112.30 | P/E Ratio | 218.92 |
| Prev. Close | $110.39 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $110.13 - $113.71 | Volume | 2,659,030 |
| 52-Wk Range | $66.89 - $145.09 | Avg. Daily Vol. | 3,044,238 |
A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.
| Current Price | $110.39 | Mkt Cap | $43.5B |
|---|---|---|---|
| Open | $112.30 | P/E Ratio | 218.92 |
| Prev. Close | $110.39 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $110.13 - $113.71 | Volume | 2,659,030 |
| 52-Wk Range | $66.89 - $145.09 | Avg. Daily Vol. | 3,044,238 |
The best Bull and Bear pitches based on recency and number of recommendations.
From Fidelity and Zacks October 2021Revenue Growth (5YR) = 36.8%Rev Change (Last Qtr vs Prior year Qtr) = 31.7%Price/Sales (TTM) = 24.8
The company is having a great year, but based on its price-to-earnings ratio and its PEG, it's still a bit overpriced compared to its peers.
Read the most recent pitches from players about DXCM.
Recs
lemiwinx
(21.00)
Submitted: 8/2/2022 10:15:52 AM :
Start Price:
$86.82
NASDAQ:DXCM Score:
+30.91
Best diabetes stock. Best in class devices for monitoring diabetes.
Recs
DZBV216
(< 20)
Submitted: 6/13/2022 10:22:35 AM :
Start Price:
$70.15
NASDAQ:DXCM Score:
+52.56
Trust in Nick Sciple
Recs
dpfriedman
(30.31)
Submitted: 1/28/2022 3:42:07 PM :
Start Price:
$102.41
NASDAQ:DXCM Score:
+17.79
Leader of the space for testing Diabetes and Americans are getting fatter everyday.
Find the members with the highest scoring picks in DXCM.
ardys13 (< 20) Score: +11,473.39
The Score Leader is the player with the highest score across all their picks in DXCM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| ardys13 | < 20 | 2/9/2009 |
|
1Y | $0.93 | +11,834.05% | +360.66% | +11,473.39 | 1 Comment | |
| bigrick22 | < 20 | 3/24/2008 |
|
NS | $1.00 | +10,939.00% | +207.45% | +10,731.55 | 0 Comment | |
| CleverKat | 66.67 | 3/24/2008 |
|
NS | $1.07 | +10,240.98% | +204.10% | +10,036.89 | 0 Comment | |
| cpalerm | 88.43 |
|
|
5Y | $1.08 | +10,121.30% | +407.19% | +9,714.11 | 1 Comment | |
| MEGIN7790 | < 20 | 4/4/2008 |
|
NS | $1.11 | +9,822.70% | +198.26% | +9,624.43 | 0 Comment | |
| LazyTimeMoney | 74.52 | 4/7/2008 |
|
NS | $1.26 | +8,661.11% | +197.76% | +8,463.35 | 0 Comment | |
| jabrink | 78.04 | 4/7/2008 |
|
3W | $1.27 | +8,609.27% | +197.52% | +8,411.75 | 0 Comment | |
| GriffinRex | 90.05 | 4/8/2008 |
|
3M | $1.29 | +8,440.81% | +200.85% | +8,239.96 | 0 Comment | |
| cash4metoo | 66.36 | 5/28/2009 |
|
1Y | $1.34 | +8,168.91% | +341.48% | +7,827.44 | 0 Comment | |
| YahooSIRIous | 94.24 | 7/13/2009 |
|
5Y | $1.34 | +8,153.46% | +349.69% | +7,803.76 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
